Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1G-CSF[1] Filgrastim[1] Filgrastim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[12] 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
2G-CSF for Conditioning before HSCT.----[1] 65 💬
3G-CSF-Primed Bone Marrow Plus Peripheral Blood Stem Cell Graft----[1] 60 💬
4G-CSF-Primed Peripheral Blood Stem Cell Graft----[1] 60 💬
5G02C B01----[1] 74 💬
6G04BE03----[1] 86 💬
7G04BE03- Sildenafil - sildenafil (citrato)[1] Sildenafil[2] Sildenafil citrate ,
Sildenafil 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
8G04BE08----[1] 86 💬
9G04CB02----[1] 2 💬
10G1117337----[2] 67, 299 💬
11G1567970----[3] 46, 53, 97 💬
12G1XCG----[1] 65 💬
13G1XCGD transduced CD34+ cells----[1] 65 💬
14G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)----[1] 13 💬
15G321605----[3] 85, 96, 97 💬
16G451990----[2] 51, 85 💬
17G914167----[1] 299 💬
18G957389----[1] 299 💬
19GA----[1] 13 💬
20GA 20 mg/mL----[1] 13 💬
21GA 40 mg/mL----[1] 13 💬
22GA Depot----[1] 13 💬
23GA Depot 25mg once monthly----[1] 13 💬
24GA Depot 40 mg----[1] 13 💬
25GA Depot 40mg once monthly----[1] 13 💬
26GA Depot 80 mg----[1] 13 💬
27Ga-68-DOTA-NOC----[1] 84 💬
28GA-GCB[1] Velaglucerase alfa[1] Velaglucerase alfa 💬 [1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
29GA-GCB (velaglucerase alfa)[1] Velaglucerase alfa[1] Velaglucerase alfa 💬 [1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
30Ga68-FAPI-46----[1] 96 💬
31GABAPENTIN[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[7] 6, 13, 18, 19, 70, 226, 298 💬
32Gabapentin (neurontin® capsule 300mg) treatment[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 70 💬
33Gabapentin prescriptions[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 298 💬
34GABAPENTINA[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 6 💬
35GABAPENTINA KERN PHARMA[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 6 💬
36Gabapentine[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 13 💬
37Gabapentine 300mg[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[2] 13, 18 💬
38Gaboxadol[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[2] 201, 206 💬
39Gaboxadol (HLX-0206)[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 206 💬
40GABOXADOL MONOHYDRATE[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
41Gaboxadol monohydrate 0.5 mg[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
42Gaboxadol monohydrate 0.5 mg (intended commercial formulation)[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
43Gaboxadol monohydrate 0.5 mg capsule[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
44Gaboxadol monohydrate 2 mg[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
45Gaboxadol monohydrate 2 mg (intended commercial formulation)[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
46Gaboxadol monohydrate 2 mg capsule[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
47Gaboxadol monohydrate 5 mg[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
48Gaboxadol monohydrate 5 mg (intended commercial formulation)[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 201 💬
49Gadobenate Dimeglumine[1] Gadobenic acid[2] Gadobenate dimeglumine ,
Gadobenic acid 💬 		--[1] 13 💬
50GADOBUTROL[1] Gadobutrol[1] Gadobutrol 💬 --[4] 13, 22, 46, 226 💬
51Gadodiamide[1] Gadodiamide[2] Gadodiamide hydrate ,
Gadodiamide 💬 		--[1] 305 💬
52Gadolinium[1] Gadolinium---[8] 13, 34, 46, 65, 77, 86, 113, 305 💬
53Gadolinium contrast[1] Gadolinium---[1] 34 💬
54Gadolinium For abdomen[1] Gadolinium---[1] 65 💬
55Gadolinium For lower back[1] Gadolinium---[1] 65 💬
56Gadolinium-based contrast[1] Gadolinium---[1] 13 💬
57Gadopentetate dimeglumine[1] Gadopentetic acid[2] Gadopentetate dimeglumine ,
Gadopentetic acid 💬 		--[2] 13, 34 💬
58Gadoterate meglumine[2] Gadoteric acid,
Meglumine		[3] Meglumine ,
Gadoterate meglumine ,
Gadoteric acid 💬 		--[2] 53, 85 💬
59Gadoteric acid[1] Gadoteric acid[2] Gadoterate meglumine ,
Gadoteric acid 💬 		--[2] 13, 58 💬
60Gadoteridol[1] Gadoteridol[1] Gadoteridol 💬 --[1] 13 💬
61GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado----[1] 13 💬
62Gadovist 1.0 mmol/ml Injektionslösung----[1] 13 💬
63Galactose[1] Galactose[1] Galactose 💬 --[4] 66, 171, 222, 257 💬
64Galafold----[1] 19 💬
65GALANTAMINE[1] Galantamine[2] Galantamine hydrobromide ,
Galantamine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[3] 6, 11, 127 💬
66Galantamine HBr extended-release 8mg capsules (8mg ER).[1] Galantamine[2] Galantamine hydrobromide ,
Galantamine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
67Galantamine hydrobromide[1] Galantamine[2] Galantamine hydrobromide ,
Galantamine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[2] 6, 127 💬
68Galcanezumab[1] Galcanezumab[1] Galcanezumab 💬 [1] CALCA 💬 [3] Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬[1] 226 💬
69Galen----[1] 162 💬
70GALEN® tablet----[2] 43, 44 💬
71GALICAFTOR[1] Galicaftor[1] Galicaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
72Gallium nitrate[2] Gallium nitrate,
Nitrate		[2] Gallium nitrate ,
Nitric acid 💬 		--[1] 299 💬
73Gallium-68 DOTATATE[1] Dotatate---[1] 84 💬
74Gallium-68-DOTA-N-Octreotide[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
75Gallium68-Dota-Noc----[1] 85 💬
76GALSULFASE[1] Galsulfase[1] Galsulfase 💬 [1] ARSB 💬 [2] Glycosaminoglycan degradation, Lysosome biogenesis 💬[1] 19 💬
77Galunisertib[1] Galunisertib[1] Galunisertib 💬 [1] TGFBR1 💬 [23] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Apelin signaling pathway, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Endocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, MAPK signaling pathway, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Relaxin signaling pathway, TGF-beta signaling pathway, Th17 cell differentiation 💬[1] 2 💬
78Galunisertib + Nerandomilast Combination[2] Galunisertib,
Nerandomilast		[2] Galunisertib ,
Nerandomilast 💬 		[2] PDE4B,
TGFBR1 💬 		[27] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Apelin signaling pathway, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Endocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, MAPK signaling pathway, Morphine addiction, Osteoclast differentiation, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, TGF-beta signaling pathway, Th17 cell differentiation, cAMP signaling pathway 💬[1] 2 💬
79Gamma Globulin----[2] 15, 50 💬
80Gamma interferon----[1] 18 💬
81Gamma- glutamylcysteine----[1] 6 💬
82Gamma-Linolenic acid----[1] 46 💬
83Gamma-secretase/Notch signalling pathway inhibitor RO4929097----[1] 74 💬
84Gamma-Tocopherol[2] Tocopherol,
gamma-Tocopherol		[1] Tocopherol 💬 --[1] 13 💬
85GAMMAGARD LIQUID----[1] 65 💬
86Gammagard S/D (Solvent/Detergent)----[1] 65 💬
87Gammaglobulin----[1] 65 💬
88Gammanorm----[2] 14, 65 💬
89Gammanorm 165 mg/mL----[1] 65 💬
90Gammaplex----[2] 63, 65 💬
91Gammaplex (5%)----[1] 65 💬
92Gammaplex (Intravenous immunoglobulin)----[1] 65 💬
93Gammaplex 10----[1] 65 💬
94Gammaplex, intravenous immunoglobulin----[1] 63 💬
95GAMUNEX 10%----[1] 11 💬
96Gamunex-C----[2] 14, 65 💬
97Ganaxolone[1] Ganaxolone[1] Ganaxolone 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[4] 145, 152, 158, 206 💬
98Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)[1] Ganaxolone[1] Ganaxolone 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 152 💬
99Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)[1] Ganaxolone[1] Ganaxolone 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 152 💬
100Ganciclovir[1] Ganciclovir[2] Ganciclovir ,
Ganciclovir sodium 💬 		--[3] 28, 60, 97 💬
101Gandouling----[1] 171 💬
102Ganoderma----[1] 6 💬
103Garadacimab[1] Garadacimab[1] Garadacimab 💬 [1] F12 💬 [1] Complement and coagulation cascades 💬[2] 65, 85 💬
104Gardasil----[1] 49 💬
105Gardasil vaccine----[1] 97 💬
106Garetosmab[1] Garetosmab[1] Garetosmab 💬 --[1] 272 💬
107Garlic[1] Garlic[1] Garlic 💬 --[1] 299 💬
108Gastro-resistant phosphatidylcholine granules----[1] 97 💬
109Gastroscopy----[1] 97 💬
110Gastrus----[1] 66 💬
111Gazyvaro----[2] 49, 222 💬
112GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO----[1] 222 💬
113GazyvaroProduct Name: ObinutuzumabProduct Code: RO5072759Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: ObinutuzumabCAS Number: 949142-50-1Current Sponsor code: RO5072759Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 1000-Trade Name: CellceptProduct Name: mycophenolate mofetilPharmaceutical Form: Film-coated tabletINN or Proposed INN: MYCOPHENOLATE MOFETILOther descriptive name: MYCOPHENOLATE MOFETILConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 500-Trade Name: CellceptProduct Name: mycophenolate mofetilPharmaceutical Form: Powder for oral suspensionINN or Proposed INN: MYCOPHENOLATE MOFETILOther descriptive name: MYCOPHENOLATE MOFETILConcentration unit: g/ml gram(s)/millilitreConcentration type: equalConcentration number: 0.2-----[1] 222 💬
114GAZYVARO® 1000 mg/40 mL----[1] 222 💬
115GB-0998----[1] 50 💬
116GB-0998 (Intravenous immunoglobulin)----[1] 11 💬
117GB002----[1] 86 💬
118GB002 (seralutinib)[1] Seralutinib[1] Seralutinib 💬 [2] PDGFRA,
PDGFRB 💬 		[22] Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Focal adhesion, Gap junction, Glioma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬[1] 86 💬
119GB002 Capsules----[1] 86 💬
120GB004----[1] 97 💬
121GB004-HCl----[1] 97 💬
122GB0139----[1] 85 💬
123GB0139 (previously known as TD139)----[1] 85 💬
124GB221----[1] 3 💬
125GB224 10mg----[1] 46 💬
126GB224 15mg----[1] 46 💬
127GB224 20mg----[1] 46 💬
128GB224 2mg----[1] 46 💬
129GB224 30mg----[1] 46 💬
130GB224 5mg----[1] 46 💬
131GB242----[1] 46 💬
132GB261----[1] 49 💬
133GBP----[2] 13, 18 💬
134GBT440----[1] 85 💬
135GBT440 300 mg capsule----[1] 85 💬
136GBT440 300 mg tablet----[1] 85 💬
137GC+HCQ----[1] 49 💬
138GC012F[1] GC012F---[6] 11, 13, 28, 46, 49, 51 💬
139GC012F CAR-T Cell Injection[1] GC012F---[2] 13, 46 💬
140GC012F injection[1] GC012F---[4] 11, 28, 49, 51 💬
141GC1008[1] Fresolimumab[1] Fresolimumab 💬 [3] TGFB1,
TGFB2,
TGFB3 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬[2] 85, 222 💬
142GC1111_0.5mg/kg----[1] 19 💬
143GC1111_1.0mg/kg----[1] 19 💬
144GC1119----[1] 19 💬
145GC1123----[1] 19 💬
146GC1130A----[1] 19 💬
147GCK 100 mg----[1] 46 💬
148GCK 200 mg----[1] 46 💬
149GCK 300 mg----[1] 46 💬
150Gcsf----[1] 65 💬
151GDC-0134[1] GDC-0134---[1] 2 💬
152GDC-0853----[3] 13, 46, 49 💬
153GDC-0853 RO7010939----[3] 13, 46, 49 💬
154GDC-6988----[1] 299 💬
155GDNF & Synchro Med Infusion System----[1] 5 💬
156GE180 PET Scan----[1] 6 💬
157GED-0301----[2] 96, 97 💬
158GED-0507-34-LEVO[1] GED-0507-34-Levo---[1] 97 💬
159GED-0507-34-Levo 160 mg[1] GED-0507-34-Levo---[1] 97 💬
160GED-0507-34-Levo 80 mg[1] GED-0507-34-Levo---[1] 97 💬
161GED0507----[1] 97 💬
162Gefapixant[1] Gefapixant[2] Gefapixant ,
Gefapixant citrate 💬 		[1] P2RX3 💬 [4] Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬[2] 85, 226 💬
163Gefitinib[1] Gefitinib[1] Gefitinib 💬 [1] EGFR 💬 [49] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬[1] 75 💬
164Gefurulimab[1] Gefurulimab[1] Gefurulimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
165Gelatin[1] Gelatin[1] Gelatin 💬 --[7] 28, 47, 62, 70, 71, 97, 269 💬
166Geleli----[1] 46 💬
167Gemcabene[1] Gemcabene---[2] 79, 265 💬
168Gemfibrozil[1] Gemfibrozil[1] Gemfibrozil 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 6, 13 💬
169GenaKumab----[1] 107 💬
170Gene Activated a-Galactosidase A----[1] 19 💬
171Gene Activated Human Glucocerebrosidase----[1] 19 💬
172Gene activated human glucocerebrosidase, velaglucerase alfa[1] Velaglucerase alfa[1] Velaglucerase alfa 💬 [1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
173Gene expressions of miRNA----[1] 46 💬
174Gene therapy----[2] 6, 19 💬
175Gene Therapy Method for CGD----[1] 65 💬
176Gene Therapy Product-MCO-010----[2] 90, 301 💬
177Gene Therapy product:vMCO-I----[1] 90 💬
178Gene Therapy-vMCO-010----[1] 301 💬
179Gene Transfer with an AAV9 Vector Expressing Human beta-galactosidase----[1] 19 💬
180Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase----[1] 19 💬
181Gene-Activated Human Glucocerebrosidase----[1] 19 💬
182Gene-Activated Human Glucocerebrosidase 200U/vial----[1] 19 💬
183Gene-Activated Human Glucocerebrosidase 400U/vial----[1] 19 💬
184Gene-modified autologous fibroblasts----[1] 36 💬
185Gene-Transduced Autologous CD34+ Stem Cells----[1] 65 💬
186General anesthesia----[1] 6 💬
187General anesthesia with tourniquet----[1] 46 💬
188General anesthesia without tourniquet----[1] 46 💬
189General Corticotherapy----[1] 35 💬
190Generic Dry Powder Inhaler----[1] 86 💬
191Generic treprostinil sodium + Standard of Care (Double Oral)[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
192Genetic HMI-203[1] HMI-203---[1] 19 💬
193Genetic: 26 common Fabry mutation types in Taiwan----[1] 19 💬
194Genetic: 2ml peripheral venous blood was collected to detect genetic genes----[1] 97 💬
195Genetic: A single blood sample for HLA typing----[3] 35, 38, 162 💬
196Genetic: AAV-GAD----[1] 6 💬
197Genetic: AAV-GAD High Dose----[1] 6 💬
198Genetic: AAV-GAD Low Dose----[1] 6 💬
199Genetic: AAV-hAADC-2----[1] 6 💬
200Genetic: AAV2/5-RPGR----[1] 90 💬
201Genetic: AAV5-hRKp.RPGR----[1] 90 💬
202Genetic: AAV5-hRKp.RPGR Intermediate Dose----[1] 90 💬
203Genetic: AAV5-hRKp.RPGR Low Dose----[1] 90 💬
204Genetic: AAVLK03hOTC----[1] 251 💬
205Genetic: AB-1001 Gene Therapy----[1] 8 💬
206Genetic: AB-1003 dose level 1----[1] 113 💬
207Genetic: AB-1003 dose level 2----[1] 113 💬
208Genetic: AB-1009 (GAA Gene)----[1] 256 💬
209Genetic: Active Comparator: Allo-HSCT----[1] 19 💬
210Genetic: ACTUS-101[1] ACTUS-101---[1] 256 💬
211Genetic: Ad5-CB-CFTR----[1] 299 💬
212Genetic: Adenoviral Vector-Mediated Gene Transfer----[1] 251 💬
213Genetic: Adipose-derived stromal vascular fraction cells----[1] 6 💬
214Genetic: ADVM-043----[1] 231 💬
215Genetic: AFTX-201----[1] 57 💬
216Genetic: All Participants----[1] 18 💬
217Genetic: ALLO-329----[2] 49, 51 💬
218Genetic: Allo-HSCT----[1] 20 💬
219Genetic: allogeneic mesenchymal stem cell transplantation----[1] 171 💬
220Genetic: ALS patients genetic characterization----[1] 2 💬
221Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----[1] 265 💬
222Genetic: Analysis of genetic modifiers----[1] 282 💬
223Genetic: Analysis of selected single nucleotide polymorphisms (SNPs)----[1] 46 💬
224Genetic: ANB-004, dose 1----[1] 3 💬
225Genetic: ANB-004, dose 2----[1] 3 💬
226Genetic: ANB-004, dose 3----[1] 3 💬
227Genetic: APOE genotype----[1] 6 💬
228Genetic: Apolipoprotein E genetic test----[1] 127 💬
229Genetic: ART-I02----[1] 46 💬
230Genetic: ASP2016----[1] 18 💬
231Genetic: ASP2957----[1] 111 💬
232Genetic: Assessment of Genetics----[1] 97 💬
233Genetic: Asthma patients----[1] 299 💬
234Genetic: AT-GTX-501----[1] 19 💬
235Genetic: Autologous cardiac stem cells (JRM-001)----[2] 210, 211 💬
236Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene----[1] 65 💬
237Genetic: Autologous CD34+ cells transduced with WASP lentiviral vector----[1] 65 💬
238Genetic: Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII----[1] 19 💬
239Genetic: AVXS-101----[1] 3 💬
240Genetic: BB-301: Dose escalation phase 1b cohort 1[1] BB-301---[1] 113 💬
241Genetic: BB-301: Dose escalation phase 1b cohort 2[1] BB-301---[1] 113 💬
242Genetic: BB-301: Dose escalation phase 1b cohort 3[1] BB-301---[1] 113 💬
243Genetic: BB-301: Dose expansion phase 2a[1] BB-301---[1] 113 💬
244Genetic: BBM-D101----[1] 113 💬
245Genetic: BBM-F101 injection----[1] 19 💬
246Genetic: BI 3720931----[1] 299 💬
247Genetic: BIIB111----[1] 90 💬
248Genetic: BIIB112----[1] 90 💬
249Genetic: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus----[1] 6 💬
250Genetic: Biobanking with genetic analysis----[3] 13, 51, 56 💬
251Genetic: biomarker identification in Parkinson disease----[1] 6 💬
252Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue----[1] 226 💬
253Genetic: Blood----[1] 2 💬
254Genetic: Blood and nasal swab sampling----[1] 137 💬
255Genetic: Blood and/or skin biopsy----[2] 90, 301 💬
256Genetic: blood draw----[1] 6 💬
257Genetic: Blood draw for optional genetic exome sequencing----[3] 3, 15, 256 💬
258Genetic: Blood or saliva sample collection----[3] 96, 97, 299 💬
259Genetic: Blood sample----[5] 8, 13, 61, 280, 294 💬
260Genetic: Blood sample for genetic analysis----[3] 2, 5, 127 💬
261Genetic: blood samples----[1] 280 💬
262Genetic: Blood sampling----[2] 13, 49 💬
263Genetic: Blood Sampling and DNA collection----[1] 6 💬
264Genetic: Blood sampling for biological and genetic analysis----[1] 19 💬
265Genetic: Blood test----[1] 107 💬
266Genetic: Blood test for CFTR Genotyping----[1] 299 💬
267Genetic: Bloodsampling----[1] 167 💬
268Genetic: Cardiac progenitor cell infusion----[2] 210, 211 💬
269Genetic: CD19 and BCMA-targeted allogeneic CAR-T cells----[1] 63 💬
270Genetic: Cell function identification----[1] 228 💬
271Genetic: CERE-120: AAV2-NTN[1] CERE-120---[1] 6 💬
272Genetic: chromosomal microarray analysis (CMA) and whole exome sequencing (WES)----[1] 179 💬
273Genetic: CL20-i4-EF1a-h?c-OPT----[1] 65 💬
274Genetic: Cohort1----[1] 6 💬
275Genetic: Cohort2----[1] 6 💬
276Genetic: Control - No Result----[1] 79 💬
277Genetic: Convection enhanced delivery/AAV2-GDNF----[1] 6 💬
278Genetic: CRG003 injection----[1] 256 💬
279Genetic: CTNS-RD-04 or CTNS-RD-04-LB (where the suffix -LB stands for LentiBOOST)----[1] 19 💬
280Genetic: Cystic fibrosis transmembrane conductance regulator[1] Cystic fibrosis transmembrane conductance regulator---[1] 299 💬
281Genetic: cytogenetic analysis----[1] 285 💬
282Genetic: Delandistrogene Moxeparvovec[1] Delandistrogene moxeparvovec[1] Delandistrogene moxeparvovec 💬 [1] DMD 💬 [5] Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬[1] 113 💬
283Genetic: Design of patient specific ASO----[3] 181, 182, 183 💬
284Genetic: DFT383----[1] 19 💬
285Genetic: Diagnosis of Fabry disease----[1] 19 💬
286Genetic: DNA Analysis----[3] 6, 28, 60 💬
287Genetic: DNA bio-banking----[1] 122 💬
288Genetic: DNA chip dedicated to the pharmacogenetic of steroids----[1] 222 💬
289Genetic: DNA sequencing----[1] 85 💬
290Genetic: DNA/GeneticTesting----[1] 6 💬
291Genetic: Dose 1 of BMN 331----[1] 65 💬
292Genetic: Dose 2 of BMN 331----[1] 65 💬
293Genetic: Dose 3 of BMN 331----[1] 65 💬
294Genetic: Dose 4 of BMN 331----[1] 65 💬
295Genetic: Dose 5 of BMN 331----[1] 65 💬
296Genetic: Dose 6 of BMN 331----[1] 65 💬
297Genetic: Dose 7 of BMN 331----[1] 65 💬
298Genetic: DTX301----[1] 251 💬
299Genetic: ECUR-506----[1] 251 💬
300Genetic: ELP-02----[1] 10 💬
301Genetic: EN-374----[1] 65 💬
302Genetic: end-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care----[2] 113, 299 💬
303Genetic: Establishment of mitochondrial markers----[1] 121 💬
304Genetic: Estimation of P.Gingivalis levels----[1] 46 💬
305Genetic: Ex-vivo approach concerning 25 patients----[3] 102, 121, 299 💬
306Genetic: ex-vivo gene-therapy----[1] 65 💬
307Genetic: EXG001-307 injection----[1] 3 💬
308Genetic: EXG110 injection----[1] 19 💬
309Genetic: Experimental: OTL-203[1] OTL-203---[1] 19 💬
310Genetic: Expression of CDKN2A /p16INK4a----[1] 46 💬
311Genetic: FACS analyses----[1] 65 💬
312Genetic: FCX-007----[1] 36 💬
313Genetic: FCX-013[1] FCX-013---[1] 51 💬
314Genetic: FLT190[1] FLT190---[1] 19 💬
315Genetic: FLT201[1] FLT201---[1] 19 💬
316Genetic: fluorescence in situ hybridization----[1] 285 💬
317Genetic: Frameshift Array blood sample test----[1] 34 💬
318Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----[1] 19 💬
319Genetic: FT-002----[1] 90 💬
320Genetic: G2019S LRRK2----[1] 6 💬
321Genetic: GC101----[1] 3 💬
322Genetic: GC101 adeno-associated virus injection----[1] 3 💬
323Genetic: GC301----[1] 256 💬
324Genetic: GC310----[1] 171 💬
325Genetic: GCB-001----[1] 3 💬
326Genetic: GCB-002----[1] 156 💬
327Genetic: GEN6050X intravenous injection----[1] 113 💬
328Genetic: Gene analysis----[1] 79 💬
329Genetic: Gene editing----[1] 228 💬
330Genetic: Gene expression by quantitative Real Time PCR----[1] 46 💬
331Genetic: gene therapy----[1] 6 💬
332Genetic: Gene-modified autologous stem cells----[1] 285 💬
333Genetic: Genetic----[1] 79 💬
334Genetic: genetic analyses----[1] 19 💬
335Genetic: genetic analysis----[8] 34, 85, 90, 93, 94, 96, 234, 265 💬
336Genetic: Genetic analysis by SANGER and WHOLE EXOME NEXT GENERATION SEQUENCING----[1] 84 💬
337Genetic: Genetic analysis of NLRP3----[1] 106 💬
338Genetic: Genetic characterization----[1] 113 💬
339Genetic: genetic diagnosis----[1] 335 💬
340Genetic: genetic polymorphisms----[1] 67 💬
341Genetic: Genetic profiling of all eligible patients----[1] 278 💬
342Genetic: genetic sequencing----[2] 40, 231 💬
343Genetic: genetic test----[1] 171 💬
344Genetic: Genetic test: ACE polymorphism----[3] 3, 15, 256 💬
345Genetic: Genetic test: ACTN3 polymorphism----[3] 3, 15, 256 💬
346Genetic: Genetic Testing----[5] 79, 89, 90, 158, 299 💬
347Genetic: Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort----[1] 113 💬
348Genetic: Genetic: whole genome sequencing----[3] 2, 6, 127 💬
349Genetic: Genome-wide association study----[1] 14 💬
350Genetic: Genome-wide DNA methylation----[1] 96 💬
351Genetic: Genomic DNA----[1] 97 💬
352Genetic: Genomic sequencing----[1] 58 💬
353Genetic: Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms----[1] 11 💬
354Genetic: Genotype Detection----[1] 49 💬
355Genetic: genotyping for three genes (TPMT, NUDT15 and FTO)----[1] 97 💬
356Genetic: Genotyping of the NPHS2 variant rs61747728----[1] 222 💬
357Genetic: GLA gene----[1] 19 💬
358Genetic: Global DNA methylation will be quantified in the DNA samples by colorimetry----[1] 63 💬
359Genetic: GS010----[1] 302 💬
360Genetic: GS010 High dose----[1] 302 💬
361Genetic: GS010 Low dose----[1] 302 💬
362Genetic: H5.001CBCFTR----[1] 299 💬
363Genetic: Healthy----[1] 6 💬
364Genetic: HG005----[1] 301 💬
365Genetic: HG204----[1] 339 💬
366Genetic: HG302----[1] 113 💬
367Genetic: High dose CLN-301----[1] 19 💬
368Genetic: High Dose LX2006[1] LX2006---[1] 18 💬
369Genetic: HLA-B*5801 test----[1] 38 💬
370Genetic: HLADQA1*05A>G screening----[2] 96, 97 💬
371Genetic: HMI-102----[1] 240 💬
372Genetic: human glucocerebrosidase cDNA----[1] 19 💬
373Genetic: human glucocerebrosidase gene into autologous peripheral blood stem cells----[1] 19 💬
374Genetic: human whole exome----[1] 285 💬
375Genetic: HYNR-CS-Allo----[1] 2 💬
376Genetic: Identification of COMT HH, COMT HL or COMT LL genes----[1] 6 💬
377Genetic: Identification of local microenvironmental changes----[1] 228 💬
378Genetic: IEM-EP----[1] 302 💬
379Genetic: In-vitro approach concerning 25 patients----[3] 102, 121, 299 💬
380Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)----[1] 65 💬
381Genetic: Infusion of autologous EFS-ADA LV CD34+ cells----[1] 65 💬
382Genetic: Infusion of lentiviral TYF-CGD-modified autologous stem cells----[1] 65 💬
383Genetic: Injecting BBM-P002 into the bilateral putamen----[1] 6 💬
384Genetic: INS1201----[1] 113 💬
385Genetic: INS1202----[1] 2 💬
386Genetic: Intervention on primary cultured cells----[1] 187 💬
387Genetic: intra-striatal rAAV5-miHTT----[1] 8 💬
388Genetic: intracerebral administration of AAVrh.10cuARSA----[1] 19 💬
389Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT----[1] 8 💬
390Genetic: Intrathalamic AVB-101[1] AVB-101---[1] 127 💬
391Genetic: Intrathecal and intravenous LV gene therapy----[2] 19, 20 💬
392Genetic: Intrathecal injection of AAV-MECP2 for the treatment of Rett syndrome----[1] 156 💬
393Genetic: ION283[1] ION283---[1] 309 💬
394Genetic: JWK006----[1] 301 💬
395Genetic: JWK008 Single intravenous infusion administration----[1] 19 💬
396Genetic: JWK010 gene therapy----[1] 164 💬
397Genetic: KL002 injection solution----[1] 6 💬
398Genetic: Laboratory Tests----[2] 113, 256 💬
399Genetic: Lenti-D----[1] 20 💬
400Genetic: Lenti-D Drug Product----[1] 20 💬
401Genetic: Lentiviral Gene Transfer----[1] 65 💬
402Genetic: Lentiviral TYF-ARSA correction of patient's autologous HSCs----[1] 19 💬
403Genetic: Low dose CLN-301----[1] 19 💬
404Genetic: Low dose LX2006[1] LX2006---[1] 18 💬
405Genetic: LY-M001----[1] 19 💬
406Genetic: LY-M003----[1] 171 💬
407Genetic: LY-M003 Injection----[1] 171 💬
408Genetic: LY3884961[1] LY3884961---[1] 19 💬
409Genetic: lymphocyte gene therapy----[1] 19 💬
410Genetic: LYS-GM101----[1] 19 💬
411Genetic: Male Rett----[1] 156 💬
412Genetic: Mesenchymal stromal cells----[1] 60 💬
413Genetic: Methylenetetrahydrofolate reductase (MTHFR) deficiency----[1] 337 💬
414Genetic: microarray analysis----[2] 28, 285 💬
415Genetic: Microbiome----[1] 97 💬
416Genetic: Mid Dose LX2006[1] LX2006---[1] 18 💬
417Genetic: miRNA----[1] 13 💬
418Genetic: Multi-omics Analysis----[1] 222 💬
419Genetic: MUNC-CD34----[1] 65 💬
420Genetic: MUNC-T3----[1] 65 💬
421Genetic: Mutation Analysis----[1] 263 💬
422Genetic: Mutation in the gene----[1] 8 💬
423Genetic: MVX-220----[1] 201 💬
424Genetic: MWAV201----[1] 171 💬
425Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)----[1] 57 💬
426Genetic: NestaCell®----[1] 8 💬
427Genetic: Next generation sequencing----[1] 171 💬
428Genetic: Next generation sequencing (NGS)----[1] 79 💬
429Genetic: NGGT002----[1] 240 💬
430Genetic: NGGT002 Injection----[1] 240 💬
431Genetic: NGGT006----[1] 79 💬
432Genetic: NGN-101[1] NGN-101---[1] 19 💬
433Genetic: NGN-401[1] NGN-401---[1] 156 💬
434Genetic: Nicotine dependence[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[1] 13 💬
435Genetic: No Intervention----[2] 19, 113 💬
436Genetic: No interventional drug product utilized in this follow-up study----[1] 20 💬
437Genetic: Non intervention-Genetic testing----[1] 6 💬
438Genetic: Non invasive prenatal diagnosis----[3] 8, 113, 206 💬
439Genetic: NTF001 Injection----[1] 2 💬
440Genetic: NVC-001 - High Dose----[1] 57 💬
441Genetic: NVC-001 - Intermediate Dose----[1] 57 💬
442Genetic: NVC-001 - Low Dose----[1] 57 💬
443Genetic: OAV101----[1] 3 💬
444Genetic: One 20cm2/10cm2 autologous skin sheet graft----[1] 160 💬
445Genetic: OPGx-BEST1----[1] 301 💬
446Genetic: Optional pharmacogenetic assessment----[1] 6 💬
447Genetic: Ornithine transcarbamylase vector[1] Ornithine[2] Ornithine ,
Ornithine aspartate 💬 		--[1] 251 💬
448Genetic: OTL-103----[1] 65 💬
449Genetic: OTL-200----[1] 19 💬
450Genetic: OTL-200 Gene Therapy----[1] 19 💬
451Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----[1] 65 💬
452Genetic: PCR polymorphism----[1] 46 💬
453Genetic: PCR-RFLP----[1] 97 💬
454Genetic: PF-06939926----[1] 113 💬
455Genetic: pGT-1 gene lipid complex----[1] 299 💬
456Genetic: PGx-guided post-operative pain management----[2] 96, 97 💬
457Genetic: PKD Patients----[1] 6 💬
458Genetic: Plerixafor[1] Plerixafor[1] Plerixafor 💬 [1] CXCR4 💬 [14] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬[1] 65 💬
459Genetic: polymerase chain reaction----[4] 28, 60, 65, 285 💬
460Genetic: Polymorphism Analysis----[2] 49, 60 💬
461Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----[1] 13 💬
462Genetic: Pre-genotype NUDT15 and optimize azathioprine dosage[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬 		--[1] 97 💬
463Genetic: protein expression analysis----[2] 28, 60 💬
464Genetic: PS-002----[1] 66 💬
465Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- First cohort----[1] 113 💬
466Genetic: rAAV2-CB-hAAT Gene Vector----[1] 231 💬
467Genetic: rAAV2-ND4----[1] 302 💬
468Genetic: rAAV2/5-PBGD vector dosage 1----[1] 254 💬
469Genetic: rAAV2/5-PBGD vector dosage 2----[1] 254 💬
470Genetic: rAAV2/5-PBGD vector dosage 3----[1] 254 💬
471Genetic: rAAV2/5-PBGD vector dosage 4----[1] 254 💬
472Genetic: Receive a pediatric-onset result----[1] 79 💬
473Genetic: Receive an adult-onset result----[1] 79 💬
474Genetic: Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase----[1] 256 💬
475Genetic: recombinant adenovirus containing the ornithine transcarbamylase gene[1] Ornithine[2] Ornithine ,
Ornithine aspartate 💬 		--[1] 251 💬
476Genetic: Resamirigene bilparvovec[1] Resamirigene bilparvovec---[1] 111 💬
477Genetic: Research Testing Performed (Laboratory)----[1] 46 💬
478Genetic: retroviral SF71-gp91phox transduced CD34+ cells----[1] 65 💬
479Genetic: Retrovirus Construct----[1] 285 💬
480Genetic: RGX-111[1] RGX-111---[1] 19 💬
481Genetic: RGX-121[1] RGX-121---[1] 19 💬
482Genetic: RGX-121-3102[1] RGX-121---[1] 19 💬
483Genetic: RGX-202----[1] 113 💬
484Genetic: RNA analysis----[3] 28, 60, 97 💬
485Genetic: RNA extraction----[1] 113 💬
486Genetic: RNA Sequencing----[1] 84 💬
487Genetic: RP-A501[1] RP-A501---[1] 32 💬
488Genetic: RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3)----[1] 57 💬
489Genetic: RTx-015----[1] 90 💬
490Genetic: RTx-021----[1] 301 💬
491Genetic: SAF-301----[1] 19 💬
492Genetic: Saliva collection (screening of all participants)----[1] 167 💬
493Genetic: Saliva sample----[2] 86, 88 💬
494Genetic: Sano Genetics Testing Kit----[1] 340 💬
495Genetic: SB-007----[1] 301 💬
496Genetic: SBT101[1] SBT101---[1] 20 💬
497Genetic: scAAV8OTC----[1] 251 💬
498Genetic: scAAV9/AGA----[1] 19 💬
499Genetic: search for polymorphisms of RASA1 gene----[1] 281 💬
500Genetic: Sequencing tests----[1] 121 💬
501Genetic: SGT-001----[1] 113 💬
502Genetic: SGT-003----[1] 113 💬
503Genetic: SHMT1 polymorphism----[1] 6 💬
504Genetic: Single - cell cloning----[1] 228 💬
505Genetic: Single dose intravenous of BBM-D101----[1] 113 💬
506Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre----[1] 65 💬
507Genetic: SKG0201 Injection----[1] 3 💬
508Genetic: Skin biopsy----[1] 6 💬
509Genetic: SPK-10001----[1] 8 💬
510Genetic: SPK-3006----[1] 256 💬
511Genetic: SPOT-03----[1] 113 💬
512Genetic: SRD-001[1] SRD-001---[2] 57, 113 💬
513Genetic: SRP-6004[1] SRP-6004---[1] 113 💬
514Genetic: SRP-9003----[1] 113 💬
515Genetic: SRP-9004----[1] 113 💬
516Genetic: ST002----[1] 34 💬
517Genetic: Stem cells----[1] 46 💬
518Genetic: Sub-Retinal Administration of OCU400-301[1] OCU400---[1] 90 💬
519Genetic: Surgical infusion of AAV-GAD into the subthalamic nucleus----[1] 6 💬
520Genetic: Taking peripheral blood samples----[1] 49 💬
521Genetic: Target Sequencing by NGS ( Next-generation sequencing)----[1] 65 💬
522Genetic: targeted gene panels analysis----[1] 86 💬
523Genetic: Telomere length----[1] 46 💬
524Genetic: tgAAC94 gene therapy vector[1] TGAAC94---[2] 46, 271 💬
525Genetic: tgAAVCF[1] tgAAVCF---[1] 299 💬
526Genetic: TN-201[1] TN-201---[1] 58 💬
527Genetic: TPMT genotyping----[2] 96, 97 💬
528Genetic: transcriptomic analysis----[1] 97 💬
529Genetic: transduced CD34+ hematopoietic stem cell----[2] 19, 20 💬
530Genetic: Triplet-primed PCR or Long-read sequencing----[1] 113 💬
531Genetic: TSHA-102[1] TSHA-102---[1] 156 💬
532Genetic: TTX-381----[1] 19 💬
533Genetic: UGX202 injection----[1] 90 💬
534Genetic: umbilical cord blood (UCB)----[1] 60 💬
535Genetic: UX701[1] UX701---[1] 171 💬
536Genetic: Vectra MBDA Test----[1] 46 💬
537Genetic: VGN-R09b injection----[1] 323 💬
538Genetic: VTx-002----[1] 2 💬
539Genetic: VTX-801[1] VTX-801---[1] 171 💬
540Genetic: whole exome sequencing----[6] 2, 6, 65, 120, 127, 149 💬
541Genetic: Whole exome sequencing - WES----[1] 64 💬
542Genetic: whole genome analysis----[1] 86 💬
543Genetic: whole genome sequencing----[3] 6, 79, 172 💬
544Genetic: whole genomic----[1] 285 💬
545Genetic: X vivo gene therapy----[1] 65 💬
546Genetic: YOLT-203----[1] 234 💬
547Genetic: YTB323----[1] 11 💬
548Genetic: ZM-02 (high dose)----[1] 90 💬
549Genetic: ZM-02 (low dose)----[1] 90 💬
550Genetic: ZM-02 (selected dose)----[1] 90 💬
551Genetic: zocaglusagene nuzaparvovec----[1] 256 💬
552Genetically corrected cultured epidermal autograft (ATMP)----[1] 36 💬
553Genetically engineered biological drugs, Janus-kinase inhibitors, tumor necrosis factor inhibitors----[1] 46 💬
554Genetically Engineered Hematopoietic Stem Progenitor Cells----[1] 285 💬
555Genetically Engineered Hematopoietic Stem/Progenitor Cells----[1] 285 💬
556Genetically modified autologous blood stem cells----[1] 65 💬
557Genetically Modified Epidermolysis Bullosa Self-Assembled Skin Substitute (GMEB-SASS)----[1] 36 💬
558Genicular nerve block----[1] 107 💬
559GENISTEIN[1] Genistein[1] Genistein 💬 --[2] 19, 299 💬
560Genistein (Unconjugated Isoflavones 100)[1] Genistein[1] Genistein 💬 --[1] 299 💬
561Genistein aglycone[1] Genistein[1] Genistein 💬 --[1] 19 💬
562Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg----[1] 299 💬
563GENOTONORM----[1] 193 💬
564Genotonorm Miniquick 0,2 mg----[1] 193 💬
565Genotropin----[6] 13, 77, 107, 187, 193, 222 💬
566Genotropin (human recombinant Growth hormone)----[1] 265 💬
567GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made.----[1] 193 💬
568Genotropin 12mg----[3] 74, 75, 78 💬
569Genotropin 5.3mg----[3] 74, 75, 78 💬
570Genotropin GoQuick----[1] 193 💬
571Genotropin MiniQuick----[1] 78 💬
572Genotropin Miniquick 0.2mg----[3] 74, 75, 78 💬
573Genotropin Miniquick 0.4mg----[3] 74, 75, 78 💬
574Genotropin Miniquick 0.6mg----[3] 74, 75, 78 💬
575Genotropin Miniquick 0.8mg----[3] 74, 75, 78 💬
576Genotropin Miniquick 1.0mg----[3] 74, 75, 78 💬
577Genotropin Miniquick 1.2mg----[3] 74, 75, 78 💬
578GENOTROPIN*1TBF 5,3MG (16UI)----[1] 274 💬
579Genoxal----[1] 222 💬
580GenPHSat injection (Efficacy)----[1] 113 💬
581GenPHSat injection (Safety)----[1] 113 💬
582GenSci048----[2] 46, 51 💬
583GenSci120----[1] 46 💬
584GenSci120 1000 mg----[1] 46 💬
585GenSci120 150 mg----[1] 46 💬
586GenSci120 600 mg----[1] 46 💬
587Gentamicin[1] Gentamicin[2] Gentamicin sulfate ,
Gentamicin 💬 		--[4] 13, 36, 113, 299 💬
588Gentamicin infusions twice a week for six months[1] Gentamicin[2] Gentamicin sulfate ,
Gentamicin 💬 		--[1] 113 💬
589Gentamicin Sulfate[1] Gentamicin[2] Gentamicin sulfate ,
Gentamicin 💬 		--[1] 36 💬
590Gentamicin sulfate 0.1% ointment[1] Gentamicin[2] Gentamicin sulfate ,
Gentamicin 💬 		--[1] 36 💬
591Gentamicin Sulfate, Injectable[1] Gentamicin[2] Gentamicin sulfate ,
Gentamicin 💬 		--[1] 36 💬
592Gentle Jogger----[1] 21 💬
593Genz-112638----[1] 19 💬
594Genz-682452-AA----[1] 19 💬
595Genz-682452-AU----[3] 6, 19, 67 💬
596Gereic Dry Powder Inhaler----[1] 86 💬
597Gerilimzumab----[1] 46 💬
598Gernebcin 80 mg----[1] 299 💬
599Gevokizumab[1] Gevokizumab[1] Gevokizumab 💬 [1] IL1B 💬 [43] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬[4] 41, 50, 56, 269 💬
600Gevokizumab open-label[1] Gevokizumab[1] Gevokizumab 💬 [1] IL1B 💬 [43] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬[1] 269 💬
601GFB-887----[2] 222, 223 💬
602GFI 38518168-AEK-B-007----[1] 46 💬
603GFT505----[2] 93, 94 💬
604GH----[1] 3 💬
605GH substitution----[1] 78 💬
606GH treatment (Somatropin)----[1] 193 💬
607GHR-LRX----[1] 77 💬
608Ghrelin----[2] 78, 299 💬
609GI-270384----[1] 97 💬
610Gilenya----[3] 2, 13, 14 💬
611GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE----[1] 13 💬
612GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE----[1] 13 💬
613GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE----[1] 13 💬
614GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE----[1] 13 💬
615GILENYA 0,5 mg cápsulas duras----[1] 14 💬
616Gilenya 0,5 mg Hartkapseln----[1] 13 💬
617Gilenya 0,5MG CPS DUR----[1] 13 💬
618Gilenya hard capsules----[1] 13 💬
619Gilenya hard capsulesProduct Name: FingolimodPharmaceutical Form: CapsuleINN or Proposed INN: FingolimodCAS Number: 162359-55-9Concentration unit: mg milligram(s)Concentration type: rangeConcentration number: 0.25-0.50Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use----[1] 13 💬
620Gilenya®----[1] 13 💬
621Gileyna----[1] 13 💬
622GILT-rhGAA[1] Reveglucosidase alfa---[1] 256 💬
623Ginger[1] Ginger[1] Ginger 💬 --[2] 46, 271 💬
624Ginkgo biloba[1] Ginkgo biloba[1] Ginkgo 💬 --[4] 13, 18, 47, 90 💬
625Ginkgo biloba pills sig: 300mg/tid[1] Ginkgo biloba[1] Ginkgo 💬 --[1] 90 💬
626Ginseng[1] Ginseng[2] Red ginseng ,
Ginseng 💬 		--[3] 13, 46, 53 💬
627GIP----[1] 299 💬
628Giving DHA-rich supplement----[1] 299 💬
629Givinostat[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[2] 107, 113 💬
630Givinostat (hydrochloride monohydrate)[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 113 💬
631Givinostat (hydrochloride-monohydrate)[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 107 💬
632GIVINOSTAT (hyrochloride monohydrate)[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 113 💬
633Givinostat (idrocloruro monoidrato)[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 113 💬
634Givinostat Hydrochloride[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 113 💬
635Givinostat Hydrochloride - Cohort 2[1] Givinostat[1] Givinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 113 💬
636Givosiran[1] Givosiran[2] Givosiran ,
Givosiran sodium 💬 		[1] ALAS1 💬 [2] Glycine, serine and threonine metabolism, Porphyrin metabolism 💬[1] 254 💬
637Givosiran (ALN-AS1)[1] Givosiran[2] Givosiran ,
Givosiran sodium 💬 		[1] ALAS1 💬 [2] Glycine, serine and threonine metabolism, Porphyrin metabolism 💬[1] 254 💬
638GKT137831----[2] 85, 93 💬
639GL-0719[1] GL-0719---[1] 61 💬
640GL-2045[1] GL-2045---[1] 63 💬
641GL701----[1] 49 💬
642Glargine----[1] 299 💬
643Glargine insulin----[1] 299 💬
644Glassia----[1] 231 💬
645Glatiramer[1] Glatiramer[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[4] 2, 13, 96, 156 💬
646GLATIRAMER ACETATE[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[3] 13, 96, 156 💬
647Glatiramer Acetate (Copaxone®)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[2] 13, 156 💬
648Glatiramer Acetate (DB)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
649Glatiramer Acetate (GA)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
650Glatiramer Acetate (GA) 40 mg[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
651Glatiramer Acetate (GTR)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
652Glatiramer Acetate (OL)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
653Glatiramer acetate 150mg enteric coated tablets[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
654Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
655Glatiramer acetate 20 mg[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
656Glatiramer acetate 20 mg, with mitoxantrone[3] Acetate,
Glatiramer,
Mitoxantrone		[3] Mitoxantrone hydrochloride ,
Glatiramer acetate ,
Mitoxantrone 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
657Glatiramer Acetate 20 mg/0.5 mL[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
658Glatiramer acetate 40 mg[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
659Glatiramer Acetate [GA][2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
660Glatiramer acetate injection with oral cetirizine hydrochloride[3] Acetate,
Cetirizine,
Glatiramer		[3] Cetirizine hydrochloride ,
Glatiramer acetate ,
Cetirizine 💬 		[21] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
HRH1 💬 		[36] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
661Glatiramer acetate with minocycline[3] Acetate,
Glatiramer,
Minocycline		[3] Minocycline hydrochloride ,
Glatiramer acetate ,
Minocycline 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
662Glatiramer acetate, (Copaxone®)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
663Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
664Glatiramer Acetate, N-Acetylcysteine[3] Acetate,
Acetylcysteine,
Glatiramer		[2] Acetylcysteine ,
Glatiramer acetate 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
665GLATIRAMER ACETATO[1] Glatiramer[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
666GLATIRAMERO ACETATO----[1] 13 💬
667Gleevec----[1] 34 💬
668Glentek 50 mg compresse rivestite con film----[1] 18 💬
669Glentek 50 mg film-coated tablets----[1] 18 💬
670Glial cell line-derived neurotrophic factor----[1] 6 💬
671Glial Cell Line-Derived Neurotrophic Factor (GDNF)----[1] 6 💬
672Glibenclamide----[1] 13 💬
673Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato----[1] 13 💬
674Gliolan----[1] 96 💬
675GLIVEC----[2] 51, 86 💬
676GLIVEC 100 mg comprimidos recubiertos con película----[2] 34, 86 💬
677Glivec 100 mg Filmtabletten----[2] 51, 86 💬
678Glivec 100 mg Hartkapsel----[1] 86 💬
679GLIVEC 400 mg comprimidos recubiertos con película----[1] 34 💬
680Glivec®----[1] 86 💬
681Glivec® 100 mg Filmtabletten----[1] 86 💬
682GlobiFer Forte----[1] 97 💬
683GLOBULINES ANTILYMPHOCYTAIRES FRESENIUS----[1] 223 💬
684GLP-1----[2] 13, 299 💬
685GLPG0259----[1] 46 💬
686GLPG0259 (Part B)----[1] 46 💬
687GLPG0259 oral capsule----[1] 46 💬
688GLPG0634----[4] 46, 96, 97, 271 💬
689GLPG0974----[1] 97 💬
690GLPG1205----[3] 85, 96, 97 💬
691GLPG1690----[2] 51, 85 💬
692GLPG1690 600 mg QD----[1] 85 💬
693GLPG1837----[1] 299 💬
694GLPG1837 dose 1----[1] 299 💬
695GLPG1837 dose 2----[1] 299 💬
696GLPG1837 dose 3----[1] 299 💬
697GLPG2222----[1] 299 💬
698GLPG2222 100 mg----[1] 299 💬
699GLPG2222 150 mg q.d.----[1] 299 💬
700GLPG2222 200 mg----[1] 299 💬
701GLPG2222 300 mg q.d.----[1] 299 💬
702GLPG2222 400 mg----[1] 299 💬
703GLPG2222 50 mg----[1] 299 💬
704GLPG2451 dose regimen A----[1] 299 💬
705GLPG2451 dose regimen B----[1] 299 💬
706GLPG2737----[2] 67, 299 💬
707GLPG2737 single dose----[1] 299 💬
708GLPG3067----[1] 299 💬
709GLPG3067 single dose----[1] 299 💬
710GLPG3667----[2] 49, 50 💬
711GLPG3970----[3] 46, 53, 97 💬
712GLPG3970 film-coated tablet----[1] 49 💬
713Glucagon[1] Glucagon[2] Glucagon ,
Glucagon hydrochloride 💬 		[1] GCGR 💬 [3] Glucagon signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 96 💬
714GLUCOCEREBROSIDASE----[1] 19 💬
715GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO----[1] 19 💬
716GlucoCorticoid----[7] 46, 49, 66, 113, 223, 228, 300 💬
717Glucocorticoid (GC)----[3] 43, 44, 46 💬
718Glucocorticoid (prednisone or prednisolone)[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
719Glucocorticoid + cytoxan----[1] 222 💬
720Glucocorticoid + tacrolimus[1] Tacrolimus[2] Tacrolimus ,
Tacrolimus 💬 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
721Glucocorticoid Agent----[1] 46 💬
722Glucocorticoid combined with cyclophosphamide induction + maintenance[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 222 💬
723Glucocorticoid Treatment----[1] 41 💬
724Glucocorticoids----[13] 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
725Glucocorticoids (GC)----[2] 43, 44 💬
726Glucocorticoids (permitted,not necessary)----[1] 46 💬
727Glucocorticoids - Reduced Dose----[2] 43, 44 💬
728Glucocorticoids - Standard Dose----[2] 43, 44 💬
729Glucocorticoids [Reduced Dose]----[2] 43, 44 💬
730Glucocorticoids [Standard Dose]----[2] 43, 44 💬
731Gluconato ferrico sodico----[1] 97 💬
732Glucophage (metformin)[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[2] 46, 75 💬
733Glucorticoid Taper Regimen----[1] 40 💬
734Glucosamine[1] Glucosamine[3] Glucosamine ,
Glucosamine hydrochloride ,
Glucosamine sulfate 💬 		--[2] 46, 271 💬
735Glucose----[3] 6, 13, 299 💬
736Glucose intake----[1] 257 💬
737Glucose Tablet----[1] 50 💬
738Glucosidase alfa----[1] 256 💬
739Glucotrace----[1] 46 💬
740GLUT1 DS----[1] 248 💬
741Glutamate and aspartate----[1] 13 💬
742Glutamine[1] L-Glutamine[1] Glutamine 💬 --[7] 87, 89, 96, 97, 113, 245, 299 💬
743Glutamine oral supplement----[1] 21 💬
744Glutamine oral supplementation----[1] 21 💬
745Glutathione[1] Glutathione[1] Glutathione 💬 --[2] 6, 299 💬
746GLUTATHIONE SODIUM[1] Glutathione[1] Glutathione 💬 --[1] 299 💬
747Gluten free diet----[1] 97 💬
748Gluten-free diet----[2] 94, 97 💬
749GLWL-01----[1] 193 💬
750Glycan----[1] 96 💬
751Glycerol Phenylbutyrate[1] Glycerol phenylbutyrate[1] Glycerol phenylbutyrate 💬 --[2] 6, 7 💬
752Glycerol Tributyrate----[2] 21, 302 💬
753Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate----[1] 13 💬
754Glycerol/Saline----[3] 316, 317, 344 💬
755Glyceryl tri-(4-phenylbutyrate)----[1] 251 💬
756Glyceryl tri-(4-phenylbutyrate)(GT4P)----[1] 251 💬
757Glyceryl Trierucate[1] Glyceryl Trierucate---[1] 20 💬
758Glyceryl trierucate/glyceryl trioleate[2] Glyceryl Trierucate,
Glyceryl Trioleate		---[1] 20 💬
759Glyceryl Trioleate[1] Glyceryl Trioleate---[1] 20 💬
760GLYCINE[1] Glycine[1] Glycine 💬 --[7] 35, 60, 86, 226, 247, 299, 340 💬
761Glycine Buffer[1] Glycine[1] Glycine 💬 --[1] 299 💬
762Glycomacropeptide-based protein substitute----[1] 240 💬
763Glycopyrrolate----[2] 6, 34 💬
764Glycosade----[3] 65, 256, 257 💬
765GlycosBio Nutritional Supplement----[1] 299 💬
766Glycosides Of Tripterygium Wilfordii Hook(GTW)----[1] 224 💬
767Glycyrrhetinic Acid----[1] 63 💬
768Glycyrrhiza glabra[1] Glycyrrhiza glabra---[1] 97 💬
769GLYCYRRHIZA GLABRA ROOT[1] Glycyrrhiza glabra---[1] 97 💬
770Glycyrrhizin and boswellic acid----[1] 46 💬
771GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.)----[1] 299 💬
772Glytactin----[1] 240 💬
773GM-CSF----[3] 51, 60, 229 💬
774GM-CSF (granulocyte-macrophage colony-stimulating factor)----[1] 229 💬
775GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)[1] Sargramostim[1] Sargramostim 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229 💬
776GM-CSF, fosfomycin and metronidazole[2] Fosfomycin,
Metronidazole		[5] Metronidazole ,
Fosfomycin tromethamine ,
Fosfomycin sodium ,
Fosfomycin ,
Metronidazole hydrochloride 💬 		--[1] 97 💬
777GM1----[1] 6 💬
778GM1 ganglioside----[1] 6 💬
779GM101----[1] 6 💬
780GM604----[1] 2 💬
781GM608----[1] 6 💬
782GMA161----[1] 63 💬
783GMA301 Injection----[1] 86 💬
784GMP compliant-BM-MSC derived sEVs----[1] 90 💬
785GMP Intervention Product----[1] 240 💬
786GNbAC1----[1] 13 💬
787GNbAC1 Monoclonal Antibody----[1] 13 💬
788GNC-038----[2] 46, 49 💬
789GNR-038, 100 ??/ kg----[1] 65 💬
790GNR-038, 100 ??/kg----[1] 65 💬
791GNR-038, 25 ??/kg----[1] 65 💬
792GNR-038, 50 ??/ kg----[1] 65 💬
793GNR-038, 50 ??/kg----[1] 65 💬
794GNR-038. The dose will be selected according to results of stage 1 clinical trial.----[1] 65 💬
795GNR-055----[1] 19 💬
796GNR-055 1.0-2.0-3.0 mg/kg----[1] 19 💬
797GNR-055 2.0 mg/kg----[1] 19 💬
798GNR-055 3.0 mg/kg----[1] 19 💬
799GNR-069----[1] 63 💬
800GNR-086----[1] 54 💬
801GnRH----[1] 74 💬
802GnRH agonist----[1] 76 💬
803GNS-3545----[1] 85 💬
804GNT0004----[1] 113 💬
805GNT0006----[1] 113 💬
806GOCOVRI----[1] 6 💬
807GOL----[1] 46 💬
808Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
809Gold Nanocrystals[1] Gold---[3] 2, 6, 13 💬
810Gold standard of visual identification and evaluation of viability of the parathyroid glands.[1] Gold---[1] 235 💬
811GOLEXANOLONE[1] Golexanolone---[1] 93 💬
812Golidocitinib[1] Golidocitinib[1] Golidocitinib 💬 [1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 60 💬
813Golidocitinib Capsules[1] Golidocitinib[1] Golidocitinib 💬 [1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 60 💬
814GOLIMUMAB[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[8] 46, 56, 84, 96, 97, 107, 270, 271 💬
815Golimumab (CNTO 148)[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271 💬
816Golimumab (GLM)[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
817Golimumab (GOL)[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 56 💬
818Golimumab (Optimization)[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
819Golimumab 1 mg per kg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
820Golimumab 100 mg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 97 💬
821Golimumab 100 mg injections[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
822Golimumab 2 mg per kg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
823Golimumab 2 mg/kg IV[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
824Golimumab 200 mg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
825Golimumab 4 mg per kg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
826Golimumab 400 mg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
827Golimumab 50 mg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 97 💬
828Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
829Golimumab 50 mg injections[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
830Golimumab 50 mg SC[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
831Golimumab Dose 1[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
832Golimumab Dose 2[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
833Golimumab Final Vialed Product (FVP)[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
834Golimumab Injection[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271 💬
835Golimumab Intravenous[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
836Golimumab Intravenous (IV)[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
837Golimumab liquid in prefilled pen[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
838Golimumab liquid in prefilled pen or Prefilled Syringe[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
839Golimumab Liquid in prefilled syringe[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[4] 46, 84, 97, 107 💬
840Golimumab Liquid in Vial[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[3] 46, 97, 271 💬
841Golimumab Pre-Filled Syringe[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 271 💬
842Golimumab prefilled pen[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
843Golimumab prefilled pen or prefilled syringe[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
844Golimumab Prefilled Syringe[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
845Golimumab treatment optimization.[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
846GOLODIRSEN[1] Golodirsen[1] Golodirsen 💬 [1] DMD 💬 [5] Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬[1] 113 💬
847Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53][1] Golodirsen[1] Golodirsen 💬 [1] DMD 💬 [5] Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬[1] 113 💬
848Gonadorelin[1] Gonadorelin[3] Gonadorelin hydrochloride ,
Gonadorelin acetate ,
Gonadorelin 💬 		[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
849Goserelin[1] Goserelin[2] Goserelin acetate ,
Goserelin 💬 		[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[2] 1, 60 💬
850Goserelin Depot[1] Goserelin[2] Goserelin acetate ,
Goserelin 💬 		[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 60 💬
851Govorestat----[1] 10 💬
852GP2013----[1] 46 💬
853GP2013 - A Proposed biosimilar rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
854GP2015----[1] 46 💬
855GP2017----[2] 46, 271 💬
856GP2017 (adalimumab biosimilar)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271 💬
857GP404141----[1] 63 💬
858Gp91 Grans----[1] 65 💬
859GPI 1485----[1] 6 💬
860GR1803 injection----[1] 49 💬
861GR181413----[1] 19 💬
862GR181413A----[1] 19 💬
863GR181413A/AT1001 capsule----[1] 19 💬
864GR181413A/AT1001 solution----[1] 19 💬
865GR3027----[1] 93 💬
866Graft intracerebral of foetal neurons----[1] 8 💬
867Graft-versus-tumor induction therapy----[2] 60, 285 💬
868Gralise----[2] 97, 226 💬
869Granocyte----[1] 18 💬
870GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)[1] Lenograstim[1] Lenograstim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 57 💬
871GRANOCYTE 34----[1] 97 💬
872Granocyte Lenograstim[1] Lenograstim[1] Lenograstim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 57 💬
873Granulated mesalamine----[1] 97 💬
874Granulocyte - colony stimulating factor (G-CSF)----[1] 2 💬
875Granulocyte Colony Stimulating Factor----[2] 2, 28 💬
876Granulocyte colony stimulating factor (G-CSF)----[1] 65 💬
877Granulocyte Colony Stimulating Factor (GCSF)----[2] 36, 57 💬
878Granulocyte Colony-Stimulating Factor----[2] 60, 296 💬
879Granulocyte colony-stimulating factor (Filgrastim)[1] Filgrastim[1] Filgrastim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 113 💬
880Granulocyte-colony stimulating factor (G-CSF) and prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
881Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)----[1] 11 💬
882Granulokine----[1] 51 💬
883Grape[1] Grape---[2] 96, 97 💬
884Grape Seed Extracts[1] Grape---[1] 97 💬
885Grapefruit[1] Grapefruit---[5] 6, 46, 50, 83, 97 💬
886Grapefruit Juice[1] Grapefruit---[1] 83 💬
887Grazoprevir[1] Grazoprevir[2] Grazoprevir ,
Grazoprevir 💬 		--[1] 223 💬
888GRC 4039----[1] 46 💬
889Green tea group----[1] 46 💬
890GREEN TEA LEAF[2] Green tea leaf,
Tea leaf		[1] Green tea leaf 💬 --[1] 17 💬
891Green Tea Polyphenols (EGCG/ECG)----[1] 6 💬
892GRF6021----[1] 6 💬
893Group 1 of patients will receive Adalimumab while Group 1 will receive ustekinumab[2] Adalimumab,
Ustekinumab		[2] Adalimumab ,
Ustekinumab 💬 		[4] IL12A,
IL12B,
IL23A,
TNF 💬 		[71] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
894Group 1 or Orencia treated group----[1] 46 💬
895Group 1- Control Diet----[1] 97 💬
896Group 1: DSL101 Low dose----[1] 171 💬
897Group 1: TollB-001 100mg qd po----[1] 46 💬
898Group 2 ustekinumab 130 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
899Group 2- UCD Diet----[1] 97 💬
900Group 2: DSL101 Medium dose----[1] 171 💬
901Group 2: TollB-001 200mg qd po----[1] 46 💬
902Group 3: DSL101 High dose----[1] 171 💬
903Group 3: TollB-001400mg qd po----[1] 46 💬
904Group 3: ustekinumab approximately 6 mg/kg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
905Group A----[1] 96 💬
906Group A SLE prospective study----[1] 49 💬
907Group AD Anti-PD + Antidepressant----[1] 6 💬
908Group B----[1] 96 💬
909Group C meningococcal conjugate vaccine----[1] 14 💬
910Group R Rasagiline[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
911Group R+AD Rasagiline + Antidepressant[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
912Growth colony stimulating factor (G-CSF)----[1] 49 💬
913Growth Hormone----[10] 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
914Growth hormone (Genotonorm® or Omnitrope®)----[1] 193 💬
915Growth Hormone (Somatropin)----[1] 2 💬
916Growth Hormone Receptor Antagonist----[1] 77 💬
917Growth Hormone Releasing Hormone----[1] 265 💬
918Growth Hormone Stimulation Test----[1] 299 💬
919GRT6019----[1] 113 💬
920GS-0151----[1] 46 💬
921GS-0272----[1] 46 💬
922GS-248----[1] 51 💬
923GS-4059----[1] 53 💬
924GS-4875----[1] 97 💬
925GS-4997 18 mg----[1] 86 💬
926GS-4997 2 mg----[1] 86 💬
927GS-4997 6 mg----[1] 86 💬
928GS-5718----[1] 46 💬
929GS-5737----[1] 299 💬
930GS-5745[1] GS-5745---[4] 46, 96, 97, 299 💬
931GS-5745 IV[1] GS-5745---[1] 97 💬
932GS-5745 SC[1] GS-5745---[1] 97 💬
933GS-6034----[4] 46, 53, 96, 97 💬
934GS-6155 white 6 mg tablets----[1] 58 💬
935GS-6615 3 mg----[1] 58 💬
936GS-6615 3 mg Pink----[1] 58 💬
937GS-6615 3 mg White----[1] 58 💬
938GS-6615 6 mg----[1] 58 💬
939GS-6615 6 mg White----[1] 58 💬
940GS-6615 pink 6 mg tablets----[1] 58 💬
941GS-6615 white 10 mg tablets----[1] 58 💬
942GS-6615 white 3 mg tablets----[1] 58 💬
943GS-6624[1] Simtuzumab---[2] 85, 94 💬
944GS-9411----[1] 299 💬
945GS-9674----[2] 93, 94 💬
946GS-9674 100 mg----[1] 93 💬
947GS-9674 30 mg----[1] 93 💬
948GS-9876----[2] 46, 53 💬
949GS010----[1] 302 💬
950GS030-DP[1] GS030-DP---[1] 90 💬
951GSH (Glutathione)[1] Glutathione[1] Glutathione 💬 --[1] 299 💬
952GSK 3196165----[1] 46 💬
953GSK1070806----[2] 56, 96 💬
954GSK1223249----[2] 2, 13 💬
955GSK1265744B (sodium salt) containing 14C-GSK1265744B----[1] 265 💬
956GSK1325760----[2] 86, 88 💬
957GSK1325760A----[1] 86 💬
958GSK1399686----[1] 97 💬
959GSK1550188----[5] 11, 49, 63, 66, 222 💬
960GSK1550188 (Belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 222 💬
961GSK1550188 1mg/kg or 10mg/kg----[1] 49 💬
962GSK1550188 IV----[1] 49 💬
963GSK1550188 SC----[1] 49 💬
964GSK1605786----[2] 96, 97 💬
965GSK1605786 500 mg----[1] 96 💬
966GSK1605786 capsule----[1] 96 💬
967GSK1605786 ChemoCentryx: formulation A----[1] 96 💬
968GSK1605786 GSK direct-fill: formulation C----[1] 96 💬
969GSK1605786 GSK modified-process: formulation D----[1] 96 💬
970GSK1605786 GSK tablet: formulation E----[1] 96 💬
971GSK1605786 GSK: formulation B----[1] 96 💬
972GSK1605786A----[2] 96, 97 💬
973GSK1827771----[1] 46 💬
974GSK1841157----[3] 13, 35, 46 💬
975GSK2018682----[1] 13 💬
976GSK2018682 CD2 Capsule----[1] 13 💬
977GSK2018682 CD3 micronised Tablet----[1] 13 💬
978GSK2018682 CD3 non-micronised Tablet----[1] 13 💬
979GSK2018682 CD3 non-micronised Tablet in fed state----[1] 13 💬
980GSK2126458----[1] 85 💬
981GSK2256098[1] GSK2256098---[1] 86 💬
982GSK2315698----[1] 28 💬
983GSK2315698 (CPHPC)----[1] 28 💬
984GSK2330672----[1] 93 💬
985GSK2330672/linerixibat 40 mg[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
986GSK2330811----[2] 51, 96 💬
987GSK2330811 Solution for Injection, 100mg/ml----[1] 51 💬
988GSK239512----[1] 13 💬
989GSK2395612----[1] 13 💬
990GSK2398852----[1] 28 💬
991GSK2398852 (unlabeled anti-SAP mAb)----[1] 28 💬
992GSK2402968----[1] 113 💬
993GSK2402968 3mg/kg/week----[1] 113 💬
994GSK2402968 6 mg/kg/week----[1] 113 💬
995GSK2402968 6mg/kg/week----[1] 113 💬
996GSK2586184----[1] 49 💬
997GSK2586184 100 mg----[1] 49 💬
998GSK2586184 200 mg----[1] 49 💬
999GSK2586184 400 mg----[1] 49 💬
1000GSK2586184 400mg----[1] 97 💬
1001GSK2586184 50 mg----[1] 49 💬
1002GSK2586184 800mg single and repeat dose----[1] 49 💬
1003GSK2586184 new formulation----[1] 49 💬
1004GSK2586184 standard formulation----[1] 49 💬
1005GSK2586881----[1] 86 💬
1006GSK2618960----[1] 53 💬
1007GSK2618960 2 mg/kg----[1] 53 💬
1008GSK2788723----[1] 19 💬
1009GSK2831781----[1] 97 💬
1010GSK2831781 - Double Blind Phase----[1] 97 💬
1011GSK2831781 - Open Label phase----[1] 97 💬
1012GSK2857916----[1] 28 💬
1013GSK2973327----[1] 41 💬
1014GSK2982772----[2] 46, 97 💬
1015GSK2982772 60 mg----[1] 46 💬
1016GSK2982772A, where A denotes the free base----[2] 46, 97 💬
1017GSK3008348----[1] 85 💬
1018GSK3008348 Nebuliser solution----[1] 85 💬
1019GSK3039294----[1] 28 💬
1020GSK3117391[1] GSK-3117391---[1] 46 💬
1021GSK3152314A----[1] 46 💬
1022GSK315234----[1] 46 💬
1023GSK315234 Injection 100mg/mL----[1] 46 💬
1024GSK3196165----[1] 46 💬
1025GSK3196165 (Otilimab)[1] Otilimab[1] Otilimab 💬 [1] CSF2 💬 [16] Acute myeloid leukemia, Amoebiasis, Coronavirus disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬[1] 46 💬
1026GSK3196165 Dose 1----[1] 46 💬
1027GSK3196165 Dose 2----[1] 46 💬
1028GSK3196165 Dose 3----[1] 46 💬
1029GSK3511294----[2] 44, 45 💬
1030GSK356278----[1] 8 💬
1031GSK3888130B----[1] 13 💬
1032GSK3915393----[1] 85 💬
1033GSK4347859----[1] 49 💬
1034GSK4527363----[1] 49 💬
1035GSK4771261----[1] 67 💬
1036GSK5926371----[1] 49 💬
1037GSK706769----[1] 46 💬
1038GSK962040----[1] 6 💬
1039GSK962040 (25 mg tablet)----[1] 6 💬
1040GT-02287----[1] 6 💬
1041GT801 Injection----[1] 61 💬
1042GTA (Glyceryl triacetate)----[1] 307 💬
1043GTA glyceryl triacetate----[1] 307 💬
1044GTA: Glyceryltriacetate----[1] 307 💬
1045GTG003.08----[1] 65 💬
1046GTR----[1] 13 💬
1047GTR.ace----[1] 13 💬
1048GTX-102----[1] 201 💬
1049GTX-102 high dose fast Period 1 and Period 2----[1] 65 💬
1050GTX-102 low dose fast Period 1 and Period 2----[1] 65 💬
1051GTX-102 medium dose fast Period 1 and Period 2----[1] 65 💬
1052GTX-102 medium dose slow Period 1 and Period 2----[1] 65 💬
1053GTX-102Product Code: GTX-102Pharmaceutical Form: Solution for injectionINN or Proposed INN: Not availableCurrent Sponsor code: GTX-102Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 11-----[1] 201 💬
1054GUANA2015----[1] 2 💬
1055GUANABENZ[1] Guanabenz[2] Guanabenz acetate ,
Guanabenz 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 2, 13 💬
1056GUANABENZ ACETATO[1] Guanabenz[2] Guanabenz acetate ,
Guanabenz 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 2 💬
1057Guanfacine[1] Guanfacine[2] Guanfacine hydrochloride ,
Guanfacine 💬 		[1] ADRA2A 💬 [4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 193 💬
1058Guanfacine Extended Release[1] Guanfacine[2] Guanfacine hydrochloride ,
Guanfacine 💬 		[1] ADRA2A 💬 [4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 193 💬
1059Guanfacine extended release (GXR)[1] Guanfacine[2] Guanfacine hydrochloride ,
Guanfacine 💬 		[1] ADRA2A 💬 [4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 193 💬
1060Guanidine[1] Guanidine[1] Guanidine hydrochloride 💬 --[2] 46, 113 💬
1061Guar gum[1] Guar gum[1] Guar gum 💬 --[1] 6 💬
1062Guideline-Directed Medical Therapy----[1] 57 💬
1063Gum Arabic----[1] 46 💬
1064Guna-Anti Interleukin 1----[1] 46 💬
1065Guna-Antiinterleukin 1 alfa----[1] 46 💬
1066Guna-Antiinterleukin 1 beta----[1] 46 💬
1067Guna-Interleukin 10----[1] 46 💬
1068Guna-Interleukin 4----[1] 46 💬
1069Gusacitinib[1] Gusacitinib[1] Gusacitinib 💬 [4] JAK1,
JAK2,
JAK3,
SYK 💬 		[49] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neutrophil extracellular trap formation, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 49 💬
1070Guselkum----[1] 97 💬
1071GUSELKUMAB[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[7] 37, 41, 51, 96, 97, 161, 269 💬
1072Guselkumab (GUS)[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1073Guselkumab (GUS), JAK inhibitors (such as upadacitinib/tofacitinib)[3] Guselkumab,
Tofacitinib,
Upadacitinib		[6] Tofacitinib citrate ,
Tofacitinib ,
Guselkumab ,
Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[5] IL23A,
JAK1,
JAK2,
JAK3,
TYK2 💬 		[44] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, C-type lectin receptor signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
1074Guselkumab (Tremfya)[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1075Guselkumab 100 mg[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 37 💬
1076Guselkumab Dose 1[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[3] 51, 96, 97 💬
1077Guselkumab Dose 2[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[3] 51, 96, 97 💬
1078Guselkumab Dose 3[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1079Guselkumab Dose 4[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
1080Guselkumab Dose 5[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
1081Guselkumab Intravenous[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 97 💬
1082Guselkumab Subcutaneous[1] Guselkumab[1] Guselkumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
1083GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use----[1] 96 💬
1084GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use----[1] 97 💬
1085Gusperimus[1] Gusperimus[2] Gusperimus trihydrochloride ,
Gusperimus 💬 		--[1] 44 💬
1086Gusperimus + glucocorticoids[1] Gusperimus[2] Gusperimus trihydrochloride ,
Gusperimus 💬 		--[1] 44 💬
1087Gut Microbial Transplantation----[1] 97 💬
1088Gut-directed budesonide and SoC[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
1089Gutron 2,5mg----[1] 58 💬
1090Gutron 5mg----[1] 58 💬
1091GV1001 0.56mg----[1] 5 💬
1092GV1001 1.12mg----[1] 5 💬
1093GVHD Prophylaxis----[3] 2, 60, 65 💬
1094GW-1000-02----[1] 13 💬
1095GW274150----[1] 46 💬
1096GW274150 Tablets----[1] 46 💬
1097GW406381----[1] 46 💬
1098GW406381X----[1] 46 💬
1099GW582892----[1] 144 💬
1100GW856553----[1] 46 💬
1101GWP42003----[1] 97 💬
1102GWP42003-P----[6] 140, 143, 144, 145, 156, 158 💬
1103GWP42003-P 10 mg/kg/day Dose----[1] 140 💬
1104GWP42003-P 20 mg/kg/day Dose----[2] 140, 144 💬
1105GWP42003-P 5 mg/kg/day Dose----[1] 140 💬
1106GX 623----[1] 135 💬
1107GX CJ7----[1] 135 💬
1108GYLENIA----[1] 13 💬
1109GYLENIA 0,5 mg----[1] 13 💬
1110GYM329[1] GYM329---[2] 3, 113 💬
1111GYPP-06 (GKT137831 free base), C10071301-D----[1] 93 💬
1112GZ/SAR402671----[2] 19, 67 💬
1113GZ385660----[1] 19 💬
1114GZ402661----[1] 79 💬
1115GZ402665----[1] 19 💬
1116GZ402666----[1] 256 💬
1117GZ402668----[1] 13 💬
1118GZ402669----[1] 222 💬
1119GZ402671----[1] 19 💬
1120GZ402671 / SAR402671----[1] 19 💬
1121GZ402673----[1] 13 💬
1122GZ419829----[1] 256 💬